306 related articles for article (PubMed ID: 31192488)
21. Healthcare burden of probable and proven invasive mucormycosis: a multi-centre cost-of-illness analysis of patients treated in tertiary care hospitals between 2003 and 2016.
Heimann SM; Vehreschild MJGT; Cornely OA; Heinz WJ; Grüner B; Silling G; Kessel J; Seidel D; Vehreschild JJ
J Hosp Infect; 2019 Mar; 101(3):339-346. PubMed ID: 30423409
[TBL] [Abstract][Full Text] [Related]
22. Mucormycosis in Children With Hematologic Malignancies: A Case Series and Review of the Literature.
Loeffen YGT; Scharloo F; Goemans BF; Heitink-Polle KMJ; Lindemans CA; van der Bruggen T; Hagen F; Wolfs TFW
Pediatr Infect Dis J; 2022 Sep; 41(9):e369-e376. PubMed ID: 35703287
[TBL] [Abstract][Full Text] [Related]
23. Mucormycosis in hematologic patients.
Pagano L; Offidani M; Fianchi L; Nosari A; Candoni A; Picardi M; Corvatta L; D'Antonio D; Girmenia C; Martino P; Del Favero A;
Haematologica; 2004 Feb; 89(2):207-14. PubMed ID: 15003897
[TBL] [Abstract][Full Text] [Related]
24. Pediatric Mucormycosis: A 10-Year Systematic Review of Reported Cases and Review of the Literature.
Otto WR; Pahud BA; Yin DE
J Pediatric Infect Dis Soc; 2019 Sep; 8(4):342-350. PubMed ID: 31181136
[TBL] [Abstract][Full Text] [Related]
25. Rhino-orbito-cerebral mucormycosis, a retrospective study of 7 cases.
Santos Gorjón P; Blanco Pérez P; Batuecas Caletrío A; Muñoz Herrera AM; Sánchez González F; de la Fuente Cañibano R
Acta Otorrinolaringol Esp; 2010; 61(1):48-53. PubMed ID: 20004878
[TBL] [Abstract][Full Text] [Related]
26. [Mucormycosis: retrospective evaluation of 12 cases].
Arda B; Erdem A; Sipahi OR; Işıkgöz Taşbakan M; Pullukçu H; Taşbakan MS; Ceylan N; Metin DY; Midilli R; Yamazhan T; Ulusoy S
Mikrobiyol Bul; 2011 Jul; 45(3):504-11. PubMed ID: 21935783
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological management of invasive mold infections in solid organ transplant recipients.
Fernández-Ruiz M
Expert Opin Pharmacother; 2024 Feb; 25(3):239-254. PubMed ID: 38436619
[TBL] [Abstract][Full Text] [Related]
28. Primary cutaneous mucormycosis in a lung transplant recipient: case report and concise review of the literature.
Page AV; Evans AJ; Snell L; Liles WC
Transpl Infect Dis; 2008 Dec; 10(6):419-25. PubMed ID: 18627579
[TBL] [Abstract][Full Text] [Related]
29. Paediatric mucormycosis: tailoring surgical strategies to compliment antifungal chemotherapy. Different strokes for different folks.
Srinivas R; Jacob TJK; Raj PM; Korula S; Mathew LG
Trop Doct; 2020 Jan; 50(1):87-90. PubMed ID: 31928201
[TBL] [Abstract][Full Text] [Related]
30. Epidemiology, clinical features, therapeutic interventions and outcomes of mucormycosis in Shiraz: an 8-year retrospective case study with comparison between children and adults.
Motamedi M; Golmohammadi Z; Yazdanpanah S; Saneian SM; Shafiekhani M
Sci Rep; 2022 Oct; 12(1):17174. PubMed ID: 36229497
[TBL] [Abstract][Full Text] [Related]
31. Increasing incidence of mucormycosis in a large Spanish hospital from 2007 to 2015: Epidemiology and microbiological characterization of the isolates.
Guinea J; Escribano P; Vena A; Muñoz P; Martínez-Jiménez MDC; Padilla B; Bouza E
PLoS One; 2017; 12(6):e0179136. PubMed ID: 28591186
[TBL] [Abstract][Full Text] [Related]
32. An Unusual Case of Pulmonary Mucormycosis.
Thomas S; Pawar B; Fernandes D; Nayar S; George P; Cherian S
Transplant Proc; 2018 Dec; 50(10):3943-3945. PubMed ID: 30503525
[TBL] [Abstract][Full Text] [Related]
33. Mucormycoses in patients with hematologic malignancies: an emerging fungal infection.
Bethge WA; Schmalzing M; Stuhler G; Schumacher U; Kröber SM; Horger M; Einsele H; Kanz L; Hebart H
Haematologica; 2005 Nov; 90 Suppl():ECR22. PubMed ID: 16266913
[TBL] [Abstract][Full Text] [Related]
34. Fungal Infections of the Stem Cell Transplant Recipient and Hematologic Malignancy Patients.
Bays DJ; Thompson GR
Infect Dis Clin North Am; 2019 Jun; 33(2):545-566. PubMed ID: 31005138
[TBL] [Abstract][Full Text] [Related]
35. A global analysis of mucormycosis in France: the RetroZygo Study (2005-2007).
Lanternier F; Dannaoui E; Morizot G; Elie C; Garcia-Hermoso D; Huerre M; Bitar D; Dromer F; Lortholary O;
Clin Infect Dis; 2012 Feb; 54 Suppl 1():S35-43. PubMed ID: 22247443
[TBL] [Abstract][Full Text] [Related]
36. Invasive fungal infections associated with prior respiratory viral infections in immunocompromised hosts.
Ajmal S; Mahmood M; Abu Saleh O; Larson J; Sohail MR
Infection; 2018 Aug; 46(4):555-558. PubMed ID: 29627936
[TBL] [Abstract][Full Text] [Related]
37. Incidence and risk factors for mucormycosis in renal transplant patients.
Downey MR; Taskar V; Linder DF; Baer SL; Waller JL; Bollag WB; Kheda M; Mohammed A; Padala S
J Investig Med; 2022 Feb; 70(2):396-401. PubMed ID: 34799422
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology and clinical manifestations of mucormycosis.
Petrikkos G; Skiada A; Lortholary O; Roilides E; Walsh TJ; Kontoyiannis DP
Clin Infect Dis; 2012 Feb; 54 Suppl 1():S23-34. PubMed ID: 22247442
[TBL] [Abstract][Full Text] [Related]
39. Postextraction Mucormycosis in Immunocompromised-Patient Management and Review of Literature.
Emodi O; Ohayon C; Bilder A; Capucha T; Wolff A; Rachmiel A
J Oral Maxillofac Surg; 2021 Jul; 79(7):1482-1491. PubMed ID: 33617788
[TBL] [Abstract][Full Text] [Related]
40. Treatment of invasive fungal sinusitis with liposomal amphotericin B: a report of four cases.
Sungkanuparph S; Sathapatayavongs B; Kunachak S; Luxameechanporn T; Cheewaruangroj W
J Med Assoc Thai; 2001 Apr; 84(4):593-601. PubMed ID: 11460976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
